CareRx (TSE:CRRX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
CareRx Corporation has reported its financial results for Q2 2024, showing an increase in adjusted EBITDA to $7.5 million despite a slight revenue dip from the previous year. The Company also faced a net loss of $1.4 million, attributed to a one-off impairment charge related to the sale of a non-core pharmacy operation. CareRx continues to drive efficiencies and manage costs to strengthen its market position in the pharmacy services sector.
For further insights into TSE:CRRX stock, check out TipRanks’ Stock Analysis page.
